跳至主要内容
临床试验/ITMCTR2100004240
ITMCTR2100004240尚未招募未知

Multicenter randomized controlled clinical trial of Tailin formulation combined with prolonged, low-dose antimicrobial therapy for recurrent urinary tract infection

Shanghai Municipal Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 70(—)
性别
All

入选标准

  • 1. In line with the RUTI diagnostic criteria of Western medicine;
  • 2. In line with the diagnostic criteria of traditional Chinese medicine;
  • 3. between the ages of 18 and 75;
  • 4. Voluntarily accept treatment and sign informed consent.

排除标准

  • 1. The first episode of acute urinary tract infection;
  • 2. Imaging examination found urinary tract congenital malformation, renal pelvis stones and other lesions;
  • 3. Urinary tract syndrome;
  • 4. Patients with stage 4-5 chronic kidney disease (CKD) (i.e. EGFR <30ml/min);
  • 5. Patients with severe heart, liver function damage or diabetes need immediate treatment;
  • 6. Patients who are allergic to two antibiotics in the antimicrobial therapy in this experiment;
  • 7. Pregnant or nursing women (women of childbearing age need to do urine HCG test to determine whether there is pregnancy);
  • 8. Severe central nervous system diseases;
  • 9. Drugs within 3 months.

研究者

相似试验

Multicenter randomized controlled clinical trial of... | 临床试验